SBIR/STTR Research Award

An Antibody Microarray for the detection of Life Signatures in Ocean World Samples

Award identifier 75f87065ac3b4565766423b5de66e329f08c47470711a6b895f4162082a7fbcbAwarding agency National Aeronautics and Space Administration

Award amount

$124,188

Program and phase

SBIR · Phase I

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Aeronautics and Space Administration
Branch
Not reported
Recipient company
GINER INC
Proposal award date
2022-07-20
Contract end date
2023-01-25
UEI
ULB2NMDNXC69
Solicitation number
SBIR_22_P1
Topic code
S13

Research abstract

One of NASArsquo;s goals is to determine if past or present life exists outside of Earth. Ocean worlds, bodies that contain liquid oceans, contain many of the key ingredients thought to be necessary for life. Ocean worlds such as Jupiterrsquo;s moon Europa and Saturnrsquo;s moons Titan and Enceladus, are all ocean worlds that are considered prospects for harboring life. NASA is currently funding efforts to develop technologies capable of detecting molecular signatures of life. Giner proposes to assist in these efforts with the invention of a life detection instrument called the Biosignature Life Chip. This instrument utilizes an antibody microarray with antibodies specific to conserved molecular markers that are widely represented in life on Earth. This approach is compatible with NASArsquo;s definition of life, which seeks organisms capable of evolution. Such organisms will likely have similar molecular features including proteins encoded by DNA and cell membranes which encapsulate organelles. Although similar microarray life detection instruments have been proposed, Ginerrsquo;s Biosignature Detection Chip is unique in that it utilizes surface plasmon resonance (SPR) for detection rather than fluorescent detection with labeled secondary antibodies. This allows for a simplified instrument which carriers fewer reagents and buffers and utilizes fewer steps than other similar devices. Ginerrsquo;s Phase I efforts will be directed toward achieving TLR3 by developing an SPR assay capable of selective and specific detection of target antigens. With the completion of Phase I, we will report on the performance of the antibody microarray including sensitivity, specificity, and selectivity for each antibody in the array. Phase II efforts will expand the number of evaluated antibodies and will include the development of a prototype SPR device.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

447 SBIR/STTR records share this UEI (1983–2025). Reported award amounts total $147,003,828. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services, Department of Energy, National Aeronautics and Space Administration, National Science Foundation, Department of Agriculture

Agency intelligence

National Aeronautics and Space Administration

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.